Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04700202 · ClinicalTrials.gov registry record
Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 132
- Enrollment target
NCT04700202 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 132 participants.
The verdict
NCT04700202 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2020-06-30 |
| Est. Completion | 2022-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04700202
The ClinicalTrials.gov registry entry for NCT04700202 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT04700202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04700202 about?
NCT04700202 is a clinical study titled "Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit". Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP.
What is the current status of trial NCT04700202?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2020-06-30. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT04700202?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04700202?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.